GlycoMimetics Inc (GLYC)
0.32
-0.01
(-3.03%)
USD |
NASDAQ |
Nov 21, 16:00
0.3104
-0.01
(-3.00%)
After-Hours: 05:22
GlycoMimetics Market Cap: 20.63M for Nov. 21, 2024
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| November 21, 2024 | 20.63M |
| November 20, 2024 | 21.28M |
| November 19, 2024 | 24.45M |
| November 18, 2024 | 26.77M |
| November 15, 2024 | 26.83M |
| November 14, 2024 | 25.75M |
| November 13, 2024 | 25.92M |
| November 12, 2024 | 25.50M |
| November 11, 2024 | 26.93M |
| November 08, 2024 | 26.59M |
| November 07, 2024 | 27.09M |
| November 06, 2024 | 24.28M |
| November 05, 2024 | 25.15M |
| November 04, 2024 | 26.44M |
| November 01, 2024 | 24.67M |
| October 31, 2024 | 26.24M |
| October 30, 2024 | 29.44M |
| October 29, 2024 | 31.60M |
| October 28, 2024 | 10.85M |
| October 25, 2024 | 11.16M |
| October 24, 2024 | 11.21M |
| October 23, 2024 | 11.45M |
| October 22, 2024 | 10.64M |
| October 21, 2024 | 10.32M |
| October 18, 2024 | 10.21M |
| Date | Value |
|---|---|
| October 17, 2024 | 10.22M |
| October 16, 2024 | 10.12M |
| October 15, 2024 | 9.827M |
| October 14, 2024 | 9.582M |
| October 11, 2024 | 9.679M |
| October 10, 2024 | 9.305M |
| October 09, 2024 | 9.254M |
| October 08, 2024 | 9.853M |
| October 07, 2024 | 10.06M |
| October 04, 2024 | 10.30M |
| October 03, 2024 | 10.33M |
| October 02, 2024 | 9.930M |
| October 01, 2024 | 10.69M |
| September 30, 2024 | 10.90M |
| September 27, 2024 | 10.77M |
| September 26, 2024 | 10.99M |
| September 25, 2024 | 10.29M |
| September 24, 2024 | 10.61M |
| September 23, 2024 | 10.61M |
| September 20, 2024 | 10.63M |
| September 19, 2024 | 10.96M |
| September 18, 2024 | 10.58M |
| September 17, 2024 | 10.64M |
| September 16, 2024 | 10.46M |
| September 13, 2024 | 10.96M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
9.254M
Minimum
Oct 09 2024
267.10M
Maximum
Dec 12 2019
108.94M
Average
106.17M
Median
Jul 29 2021
Market Cap Benchmarks
| Biomarin Pharmaceutical Inc | 12.09B |
| Arbutus Biopharma Corp | 655.64M |
| Revance Therapeutics Inc | 402.83M |
| FibroGen Inc | 39.02M |
| Cidara Therapeutics Inc | 122.96M |
Market Cap Related Metrics
| Price to Book Value | 1.814 |
| Price | 0.32 |
| Earnings Yield | -193.8% |